Jennifer R Cochran

This inventor holds 42 USPTO granted patents and 33 published patent applications, plus 5 CIPO patents and 7 EPO patents, primarily in Fusion Proteins. Top assignees: Leland Stanford Junior University, Xcella Biosciences, Inc., Aravive Biologics, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer R Cochran. Retrieved from https://idiyas.com/inventor/jennifer-r-cochran

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 42 (Patent Applications = 33)

% Patents Active = 69.0

CIPO Patents = 5 (Patent Applications = 13)

EPO Patents = 7 (Patent Applications = 22)

Average Co-Inventor Count = 3.4

ph-index = 6

Forward Citations = 140(Granted Patents)

Company Filing History:

35 out of 5,512

Leland Stanford Junior University

patents

4 out of 9

Xcella Biosciences, Inc.

patents

3 out of 5

Aravive Biologics, Inc.

patents

4. 2 out of 2

Nodus Therapeutics, Inc.

patents

5. 1 out of 8,586

Massachusetts Institute of Technology

patents

6. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Fusion Proteins

Knottin Peptides

Microcapillary Arrays

Cancer Treatment

Integrin Binding

Polypeptides

AXL Signaling

Tumor Therapy

Peptide Engineering

Screening Methods

Vascular Endothelial Growth Factor

Ciliary Neurotrophic Factor

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12691160 - ENGINEERED FIBROBLAST GROWTH FACTOR 1 VARIANTS WITH INCREASED PROTEOLYTIC STABILITY (2026-07-28),

2. 12240882 - Fusion proteins comprising an engineered knottin peptide and uses thereof (2025-03-04),

3. 12049490 - Soluble leukemia inhibitory factor receptor polypeptides and methods of using same for inhibiting leukemia inhibitory factor activity (2024-07-30),

4. 12024705 - Methods and systems for screening using microcapillary arrays (2024-07-02),

5. 11498952 - Fusion proteins comprising an engineered knottin peptide and uses thereof (2022-11-15),

6. 11473081 - Methods and systems for screening using microcapillary arrays (2022-10-18),

7. 11466063 - Conjugated knottin mini-proteins containing non-natural amino acids (2022-10-11),

8. 11446356 - Peptides and related compositions and methods (2022-09-20),

9. 11208462 - Ciliary neurotrophic factor receptor ligand-binding agents and methods of using the same (2021-12-28),

10. 11179441 - Ciliary neurotrophic factor receptor ligands and methods of using the same (2021-11-23),

11. 11136563 - Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy (2021-10-05),

12. 11096989 - Synergistic tumor treatment with an extended pharmacokinetic IL-2 and integrin-binding-Fc fusion protein (2021-08-24),

13. 11085039 - Methods and systems for screening using microcapillary arrays (2021-08-10),

14. 10888603 - Methods of treating cancer cells expressing tumor-associated integrins (2021-01-12),

15. 10844106 - Fusion proteins comprising an engineered knottin peptide and uses thereof (2020-11-24),

Title: Jennifer R Cochran - Pioneering Inventor from Stanford, CA

Introduction: Jennifer R Cochran is a highly accomplished inventor based in Stanford, CA, known for her groundbreaking work in the field of biotechnology and medical devices.

Latest Patents: Jennifer R Cochran holds several patents related to innovative drug delivery systems and biomaterials, revolutionizing the way treatments are administered and improving patient outcomes.

Career Highlights: With a distinguished career spanning over two decades, Jennifer R Cochran has been at the forefront of developing cutting-edge technologies that have the potential to transform the healthcare industry.

Collaborations: Throughout her career, Jennifer R Cochran has collaborated with leading researchers, medical professionals, and industry experts to bring her inventions from concept to reality, ensuring their practical application and impact.

Conclusion: Jennifer R Cochran's dedication to innovation and her relentless pursuit of excellence have solidified her reputation as a trailblazing inventor in the field of biotechnology, making significant contributions to the advancement of medical science.

Profile summary based on public USPTO records.